AstraZeneca settles with Ranbaxy to stave off generic Nexium launch
April 15 2008
AstraZeneca settled a patent dispute with Ranbaxy, which had threatened an "at risk" early generic launch against AstraZeneca's $5.5 billion ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.